D61.1 Drug-induced aplastic anemia

Name of the Condition

• Drug-induced aplastic anemia (ICD-10 Code D61.1)

Summary

Drug-induced aplastic anemia is a condition where the bone marrow fails to produce sufficient blood cells due to exposure to certain medications. This results in anemia, increased infection risk, and bleeding tendencies. The condition is directly linked to drug exposure and typically resolves if the offending agent is discontinued, though recovery may take time.

Causes

The primary cause is exposure to specific drugs or chemicals that damage bone marrow function. Common culprits include certain antibiotics, anticonvulsants, nonsteroidal anti-inflammatory drugs (NSAIDs), and chemotherapeutic agents. The exact mechanism often involves direct toxicity or immune-mediated destruction of hematopoietic stem cells.

Risk Factors

• Recent use of medications known to cause bone marrow suppression.
• Prolonged or high-dose exposure to potentially marrow-toxic drugs.
• Genetic predisposition to drug-induced marrow injury.
• Concurrent use of multiple marrow-suppressing agents.

Symptoms

• Fatigue, weakness, and pallor from anemia.
• Frequent or severe infections due to low white blood cell counts.
• Easy bruising, nosebleeds, or prolonged bleeding from minor injuries caused by low platelet counts.
• Shortness of breath or dizziness, especially with exertion.

Diagnosis

Diagnosis involves blood tests showing reduced red blood cell, white blood cell, and platelet counts. A bone marrow biopsy confirms decreased or absent blood-forming cells. History of drug exposure is critical, and tests may rule out other causes of aplastic anemia.

Treatment Options

• Discontinuation of the offending drug is the first step.
• Supportive care, including blood transfusions or antibiotics, may be needed.
• Immunosuppressive therapy or bone marrow transplantation may be considered in severe cases.

Prognosis and Follow-Up

Prognosis depends on the severity of marrow damage and timely removal of the causative drug. Most patients improve with drug cessation, but recovery can take weeks to months. Regular monitoring of blood counts is essential to track progress and detect complications.

Complications

• Severe anemia requiring transfusions.
• Life-threatening infections from neutropenia.
• Uncontrolled bleeding due to thrombocytopenia.
• Potential progression to chronic bone marrow failure.

Lifestyle & Prevention

• Avoid known marrow-toxic medications when possible.
• Inform healthcare providers of all medications, including over-the-counter drugs.
• Follow prescribed dosages and report new symptoms promptly.
• Maintain good hygiene to reduce infection risk during recovery.

When to Seek Professional Help

Seek immediate medical attention for unexplained fatigue, fever, unusual bleeding, or signs of infection. Discontinue any suspected drug and contact a healthcare provider if symptoms worsen or new ones appear.

Tips for Medical Coders

Document the specific drug or agent causing the aplastic anemia, as this is critical for accurate coding. Include details on drug exposure timing, discontinuation, and any associated treatments. Ensure the diagnosis aligns with clinical findings and drug history to support the D61.1 code assignment.